{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:18:39Z","timestamp":1790651919583,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013965","name":"Eastern Virginia Medical School","doi-asserted-by":"publisher","award":["Summer Scholars' Stipend"],"award-info":[{"award-number":["Summer Scholars' Stipend"]}],"id":[{"id":"10.13039\/100013965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 impacted all students, especially those with attention deficit hyperactivity disorder (ADHD), putting them at risk for disruption to their medication regimen and school performance. Our study aimed to identify if ADHD medication regimens were disrupted through analyzing prescription refills and if telehealth management demonstrated a higher rate of adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 396 patients from the General Academic Pediatrics (GAP) clinic at Children\u2019s Hospital of The King\u2019s Daughters (CHKD) were included in the study. Patients were between the ages of 8\u201318 with a history of ADHD for three or more years that was medically managed with four or more prescription refills between January 2019 and May 2022. A retrospective chart review collected age, sex, race, refill schedule, appointment schedule, and number of telehealth appointments. Data analysis compared the variables and defined \u201cpre-pandemic months\u201d as January 2019 through March 2020 and \u201cpandemic months\u201d as April 2020 through June 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The total percentage of patients who had their ADHD medications during pre-pandemic months ranged from 40 to 66% versus 31\u201344% during pandemic months. Additionally, the total percentage of patients who had quarterly ADHD management appointments during pre-pandemic months ranged between 59 and 70% versus 33\u201350% during pandemic months. The number of months with ADHD prescription refills over the last three years was significantly higher among those who had both virtual and in-person visits than those who had just in-person visits,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001. Regarding race, Black patients had a lower number of medication refills compared to White patients when controlled for appointment type. They also had a lower number of total appointments, but there was not a significant difference in the number of virtual appointments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Since the start of the pandemic, ADHD patients have both refilled their prescriptions and returned to clinic less frequently. This data suggests a need to re-evaluate the ADHD symptoms of GAP patients periodically and return them to a more consistent medication regimen. Telehealth appointments are a potential solution to increase adherence. However, racial inequities found in this study need to be addressed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-024-05623-4","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T08:05:08Z","timestamp":1709798708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["ADHD prescription patterns and medication adherence in children and adolescents during the COVID-19 pandemic in an urban academic setting"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5433-9362","authenticated-orcid":false,"given":"Peter J.","family":"Cunniff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amil","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McCrary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan H.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turaj","family":"Vazifedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-953X","authenticated-orcid":false,"given":"John W.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"7","key":"5623_CR1","first-page":"456","volume":"90","author":"BT Felt","year":"2014","unstructured":"Felt BT, Biermann B, Christner JG, Kochhar P, Harrison RV. Diagnosis and management of ADHD in children. Am Fam Physician. 2014;90(7):456\u201364.","journal-title":"Am Fam Physician"},{"issue":"12","key":"5623_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/children8121134","volume":"8","author":"E Panagouli","year":"2021","unstructured":"Panagouli E, Stavridou A, Savvidi C, Kourti A, Psaltopoulou T, Sergentanis TN, Tsitsika A. School Performance among children and adolescents during COVID-19 pandemic: a systematic review. Children. 2021;8(12):1134.","journal-title":"Children"},{"issue":"11","key":"5623_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1037\/pas0001267","volume":"35","author":"MK Colvin","year":"2023","unstructured":"Colvin MK, Koven MR, Vuijk PJ, Fleming LE, Reese KL, Cassill C, Beery CS, Braaten EB, Doyle AE. Differences in cognitive and academic performance during the COVID-19 pandemic in child psychiatric outpatients. Psychol Assess. 2023;35(11):1000\u20139.","journal-title":"Psychol Assess"},{"issue":"6","key":"5623_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jadohealth.2020.09.00","volume":"67","author":"SP Becker","year":"2020","unstructured":"Becker SP, Breaux R, Cusick CN, et al. Remote learning during COVID-19: Examining School practices, Service Continuation, and difficulties for adolescents with and without Attention-Deficit\/Hyperactivity disorder. J Adolesc Health. 2020;67(6):769\u201377. https:\/\/doi.org\/10.1016\/j.jadohealth.2020.09.00.","journal-title":"J Adolesc Health"},{"issue":"1","key":"5623_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jaac.2020.09.011","volume":"60","author":"J Summers","year":"2021","unstructured":"Summers J, Baribeau D, Mockford M, Goldhopf L, Ambrozewicz P, Szatmari P, Vorstman J. Supporting children with neurodevelopmental disorders during the COVID-19 pandemic. J Am Acad Child Adolesc Psychiatry. 2021;60(1):2\u20136.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"5623_CR6","doi-asserted-by":"publisher","unstructured":"Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder (ADHD) in children and adolescents. Pediatr Collections: ADHD: Evaluation Care. 2019;7\u201331. https:\/\/doi.org\/10.1542\/9781610024129-part01-clinical.","DOI":"10.1542\/9781610024129-part01-clinical"},{"issue":"4","key":"5623_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaac.2018.11.014","volume":"58","author":"A Jangmo","year":"2019","unstructured":"Jangmo A, St\u00e5lhandske A, Chang Z, et al. Attention-Deficit\/Hyperactivity disorder, School Performance, and Effect of Medication. J Am Acad Child Adolesc Psychiatry. 2019;58(4):423\u201332. https:\/\/doi.org\/10.1016\/j.jaac.2018.11.014.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3S","key":"5623_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.encep.2020.05.01","volume":"46","author":"E Bobo","year":"2020","unstructured":"Bobo E, Lin L, Acquaviva E, et al. Comment les enfants et adolescents avec le trouble d\u00e9ficit d\u2019attention\/hyperactivit\u00e9 (TDAH) vivent-ils Le confinement durant la pand\u00e9mie COVID-19? [How do children and adolescents with attention deficit hyperactivity disorder (ADHD) experience lockdown during the COVID-19 outbreak?]. Encephale. 2020;46(3S):85\u2013S92. https:\/\/doi.org\/10.1016\/j.encep.2020.05.01.","journal-title":"Encephale"},{"issue":"6","key":"5623_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/10870547211027640","volume":"26","author":"V Tessarollo","year":"2022","unstructured":"Tessarollo V, Scarpellini F, Costantino I, Cartabia M, Canevini MP, Bonati M. Distance Learning in Children with and without ADHD: a case-control study during the COVID-19 pandemic. J Atten Disord. 2022;26(6):902\u201314.","journal-title":"J Atten Disord"},{"key":"5623_CR10","unstructured":"AJMC Staff. A Timeline of COVID-19 developments in 2020. Am J Managed Care January 1, 2021."},{"issue":"2","key":"5623_CR11","doi-asserted-by":"publisher","first-page":"e2021049972","DOI":"10.1542\/peds.2021-049972","volume":"148","author":"KP Chua","year":"2021","unstructured":"Chua KP, Volerman A, Conti RM. Prescription drug dispensing to US children during the COVID-19 pandemic. Pediatrics. 2021;148(2):e2021049972. https:\/\/doi.org\/10.1542\/peds.2021-049972.","journal-title":"Pediatrics"},{"key":"5623_CR12","doi-asserted-by":"publisher","unstructured":"Clement J, Jacobi M, Greenwood BN. Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One. 2021;16(4):e0249453. Published 2021 Apr 1. https:\/\/doi.org\/10.1371\/journal.pone.0249453.","DOI":"10.1371\/journal.pone.0249453"},{"issue":"8","key":"5623_CR13","doi-asserted-by":"publisher","first-page":"e060961","DOI":"10.1136\/bmjopen-2022-060961","volume":"12","author":"A Bottle","year":"2022","unstructured":"Bottle A, Neale FK, Foley KA, et al. Impact of COVID-19 on outpatient appointments in children and young people in England: an observational study. BMJ Open. 2022;12(8):e060961. https:\/\/doi.org\/10.1136\/bmjopen-2022-060961. Published 2022 Aug 8.","journal-title":"BMJ Open"},{"issue":"3","key":"5623_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3934\/publichealth.2022037","volume":"9","author":"MO Ogundele","year":"2022","unstructured":"Ogundele MO, Ayyash HF, Ani C. The impact of Covid-19 pandemic on services for children and adolescents with ADHD: results from a survey of paediatricians in the United Kingdom. AIMS Public Health. 2022;9(3):542\u201351. https:\/\/doi.org\/10.3934\/publichealth.2022037. Published 2022 Jun 21.","journal-title":"AIMS Public Health"},{"issue":"6","key":"5623_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S2352-4642(20)30110-3","volume":"4","author":"S Cortese","year":"2020","unstructured":"Cortese S, Asherson P, Sonuga-Barke E, et al. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health. 2020;4(6):412\u20134. https:\/\/doi.org\/10.1016\/S2352-4642(20)30110-3.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"5623_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/jcpp.13584","volume":"63","author":"MA Stein","year":"2022","unstructured":"Stein MA, Editorial Perspective. COVID-19, ADHD management and telehealth: uncertain path. J Child Psychol Psychiatry. 2022;63(7):829\u201331. https:\/\/doi.org\/10.1111\/jcpp.13584.","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"5623_CR17","doi-asserted-by":"publisher","first-page":"100949","DOI":"10.1016\/j.cppeds.2021.100949","volume":"51","author":"R Ros-DeMarize","year":"2021","unstructured":"Ros-DeMarize R, Chung P, Stewart R. Pediatric behavioral telehealth in the age of COVID-19: brief evidence review and practice considerations. Curr Probl Pediatr Adolesc Health Care. 2021;51(1):100949. https:\/\/doi.org\/10.1016\/j.cppeds.2021.100949.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"4","key":"5623_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jaac.2015.01.009","volume":"54","author":"K Myers","year":"2015","unstructured":"Myers K, Vander Stoep A, Zhou C, McCarty CA, Katon W. Effectiveness of a telehealth service delivery model for treating attention-deficit\/hyperactivity disorder: a community-based randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(4):263\u201374. https:\/\/doi.org\/10.1016\/j.jaac.2015.01.009.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"5623_CR19","doi-asserted-by":"publisher","first-page":"e0249237","DOI":"10.1371\/journal.pone.0249237","volume":"16","author":"M Adamou","year":"2021","unstructured":"Adamou M, Jones SL, Fullen T, Galab N, Abbott K, Yasmeen S. Remote assessment in adults with autism or ADHD: a service user satisfaction survey. PLoS ONE. 2021;16(3):e0249237. https:\/\/doi.org\/10.1371\/journal.pone.0249237. Published 2021 Mar 25.","journal-title":"PLoS ONE"},{"issue":"1","key":"5623_CR20","doi-asserted-by":"publisher","first-page":"e22696","DOI":"10.2196\/22696","volume":"4","author":"AC Shah","year":"2021","unstructured":"Shah AC, Badawy SM. Telemedicine in Pediatrics: systematic review of Randomized controlled trials. JMIR Pediatr Parent. 2021;4(1):e22696. https:\/\/doi.org\/10.2196\/22696. Published 2021 Feb 24.","journal-title":"JMIR Pediatr Parent"},{"issue":"8","key":"5623_CR21","first-page":"657","volume":"79","author":"R Rader","year":"2009","unstructured":"Rader R, McCauley L, Callen EC. Current strategies in the diagnosis and treatment of childhood attention-deficit\/hyperactivity disorder. Am Fam Physician. 2009;79(8):657\u201365.","journal-title":"Am Fam Physician"},{"issue":"10","key":"5623_CR22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s10802-023-01093-6","volume":"51","author":"BM Merrill","year":"2023","unstructured":"Merrill BM, Macphee FL, Burrows-MacLean L, Coles EK, Wymbs BT, Chacko A, Walker K, Wymbs F, Garefino A, Robb Mazzant J, Gnagy EM, Waxmonsky JG, Massetti GM, Waschbusch DA, Fabiano GA, Pelham WE Jr. Single and combined effects of multiple intensities of behavioral modification and methylphenidate for children with ADHD in the home setting. Res Child Adolesc Psychopathol. 2023;51(10):1481\u201395.","journal-title":"Res Child Adolesc Psychopathol"},{"key":"5623_CR23","unstructured":"Camera L. Pandemic prompts historic decline in Student Achievement on Nation\u2019s Report Card. Volume 24. U.S. News & World Report; 2022."},{"key":"5623_CR24","unstructured":"Virginia Department of Education. Standards of Learning Test Pass Rates & Other Results. 2022."},{"key":"5623_CR25","unstructured":"Llamas M. Adderall Shortage Continues as FDA assists manufacturers. Drugwatch. October 20, 2022."},{"key":"5623_CR26","unstructured":"Chuck E. FDA confirms Adderall shortage as largest manufacturer warns of delays through end of the year. NBC News Oct 13, 2022."},{"issue":"5","key":"5623_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jaac.2011.02.007","volume":"50","author":"SC Marcus","year":"2011","unstructured":"Marcus SC, Durkin M. Stimulant adherence and academic performance in urban youth with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(5):480\u20139. https:\/\/doi.org\/10.1016\/j.jaac.2011.02.007.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"5623_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3810\/pgm.2012.05.2557","volume":"124","author":"J Lachaine","year":"2012","unstructured":"Lachaine J, Beauchemin C, Sasane R, Hodgkins PS. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Postgrad Med. 2012;124(3):139\u201348. https:\/\/doi.org\/10.3810\/pgm.2012.05.2557.","journal-title":"Postgrad Med"},{"issue":"5","key":"5623_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","volume":"48","author":"BSG Molina","year":"2009","unstructured":"Molina BSG, Hinshaw SP, Swanson JM, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484\u2013500. https:\/\/doi.org\/10.1097\/CHI.0b013e31819c23d0.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"5623_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11920-013-0371-6","volume":"15","author":"A Charach","year":"2013","unstructured":"Charach A, Fernandez R. Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep. 2013;15(7):371. https:\/\/doi.org\/10.1007\/s11920-013-0371-6.","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"5623_CR31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/vaccines10111828","volume":"10","author":"AM Temple","year":"2022","unstructured":"Temple AM, Schendler E, Harrington J. Parent\u2019s hesitation with COVID-19 vaccinations in infants and children aged 6 months to 5 years. Vaccines. 2022;10(11):1828.","journal-title":"Vaccines"},{"issue":"8","key":"5623_CR32","first-page":"25","volume":"18","author":"KI Kamimura-Nishimura","year":"2019","unstructured":"Kamimura-Nishimura KI, Brinkman WB, Froehlich TE. Strategies for improving ADHD medication adherence. Curr Psychiatr. 2019;18(8):25\u201338.","journal-title":"Curr Psychiatr"},{"key":"5623_CR33","unstructured":"National Committee for Quality Assurance. Guidelines for HEDIS effectiveness of Care measures: Follow-Up care for children prescribed ADHD medication. Superior Healthplan; 2022."},{"key":"5623_CR34","doi-asserted-by":"publisher","unstructured":"Bemanalizadeh M, Yazdi M, Yaghini O, Kelishadi R. A meta-analysis on the effect of telemedicine on the management of attention deficit and hyperactivity disorder in children and adolescents [published online ahead of print, 2021 Oct 11]. J Telemed Telecare. 2021;1357633X211045186. https:\/\/doi.org\/10.1177\/1357633X211045186.","DOI":"10.1177\/1357633X211045186"},{"issue":"7","key":"5623_CR35","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.acap.2021.04.004","volume":"21","author":"A Milne Wenderlich","year":"2021","unstructured":"Milne Wenderlich A, Li R, Baldwin CD, Contento N, Herendeen N, Rand CM. A Quality Improvement Initiative to improve Attention-Deficit\/Hyperactivity disorder Follow-Up rates using School-based telemedicine. Acad Pediatr. 2021;21(7):1253\u201361. https:\/\/doi.org\/10.1016\/j.acap.2021.04.004.","journal-title":"Acad Pediatr"},{"issue":"2","key":"5623_CR36","first-page":"59","volume":"55","author":"O Weisman","year":"2018","unstructured":"Weisman O, Schonherz Y, Harel T, Efron M, Elazar M, Gothelf D. Testing the efficacy of a Smartphone application in improving Medication Adherence, among children with ADHD. Isr J Psychiatry. 2018;55(2):59\u201363.","journal-title":"Isr J Psychiatry"},{"issue":"1157","key":"5623_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/postgradmedj-2020-139116","volume":"98","author":"J Hong","year":"2022","unstructured":"Hong J, Tiu YC, Leung PYB, Wong MF, Ng WY, Cheung D, Mok HY, Lam WY, Li KY, Wong CK. Interventions that improve adherence to antihypertensive medications in coronary heart disease patients: a systematic review. Postgrad Med J. 2022;98(1157):219\u201327. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139116.","journal-title":"Postgrad Med J"},{"key":"5623_CR38","doi-asserted-by":"publisher","first-page":"e44297","DOI":"10.2196\/44297","volume":"8","author":"A Rai","year":"2023","unstructured":"Rai A, Riddle M, Mishra R, Nguyen N, Valine K, Fenney M. Use of a smartphone-based medication adherence platform to improve outcomes in uncontrolled type 2 diabetes among veterans: prospective case-crossover study. JMIR Diabetes. 2023;8:e44297. https:\/\/doi.org\/10.2196\/44297. Published 2023 Aug 10.","journal-title":"JMIR Diabetes"},{"issue":"2","key":"5623_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1258\/1357633053499886","volume":"11","author":"NM Hjelm","year":"2005","unstructured":"Hjelm NM. Benefits and drawbacks of telemedicine. J Telemed Telecare. 2005;11(2):60\u201370. https:\/\/doi.org\/10.1258\/1357633053499886.","journal-title":"J Telemed Telecare"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05623-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05623-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05623-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T13:03:00Z","timestamp":1710075780000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05623-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5623"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05623-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3179535\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Children\u2019s Hospital of the King\u2019s Daughters approved this study. Informed consent was waived by the Institutional Review Board of Human Subjects\u2019 Protections at Eastern Virginia Medical School. All subject data is de-identified. IRB number 22-05-WC-0110.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}